Showing results (601-610 of 648) with videos related to

Sort By:
Pageof 65
Research Square|June 17, 2024
Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple MyelomaMalin Hultcrantz, Hani Hassoun, Neha Korde, et al.
The Lancet. Haematology|May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trialBenjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Robust CD4+ CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene AutoleucelEric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Transplantation and Cellular Therapy|March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHDMuna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Blood|August 15, 2018
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapiesUrvi A Shah, Elaine Y Chung, Orsi Giricz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2023
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised PatientsGhady Haidar, Jana L Jacobs, Kailey Hughes Kramer, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.
The Journal of Infectious Diseases|November 16, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised IndividualsGhady Haidar, Jacob C Hodges, Andrew Bilderback, et al.
Journal of Critical Care|October 19, 2025
Consensus statement on standards for neurocritical care units in low-income and middle-income countries (LMICs)Gentle S Shrestha, Hemanshu Prabhakar, Charu Mahajan, et al.
Muscle & Nerve|April 16, 2022
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophyJeffrey M Statland, Craig Campbell, Urvi Desai, et al.
Pageof 65